Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells

被引:3
|
作者
van Hugte, Eline [1 ,2 ]
Kasri, Nael Nadif [1 ,3 ]
机构
[1] Radboudumc, Donders Inst Brain Cognit & Behav, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands
[2] Acad Ctr Epileptol Kempenhaeghe, Heeze, Netherlands
[3] Radboudumc, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, Nijmegen, Netherlands
关键词
Autism; Bipolar disorder; Disease modeling; iPSCs; Neuropsychiatric disorders; Neuronal differentiation; Schizophrenia; Human-induced pluripotent stem cells; HUMAN BRAIN; HUMAN FIBROBLASTS; BIPOLAR DISORDER; PYRAMIDAL NEURONS; DIRECT CONVERSION; RETT-SYNDROME; HUMAN ES; SCHIZOPHRENIA; MICROGLIA; GABA;
D O I
10.1007/978-981-32-9721-0_15
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Neuropsychiatric disorders are a heterogeneous group of disorders that are challenging to model and treat, due to their underlying complex genetic architecture and clinical variability. Presently, increasingly more studies are making use of induced pluripotent stem cell (iPSC)-derived neurons, reprogrammed from patient somatic cells, to model neuropsychiatric disorders. iPSC-derived neurons offer the possibility to recapitulate relevant disease biology in the context of the individual patient genetic background. In addition to disease modeling, iPSC-derived neurons offer unprecedented opportunities in drug screening. In this chapter, the current status of iPSC disease modeling for neuropsychiatric disorders is presented. Both 2D and 3D disease modeling approaches are discussed as well as the generation of different neuronal cell types that are relevant for studying neuropsychiatric disorders. Moreover, the advantages and limitations are highlighted in addition to the future perspectives of using iPSC-derived neurons in the uncovering of robust cellular phenotypes that consecutively have the potential to lead to clinical developments.
引用
收藏
页码:297 / 312
页数:16
相关论文
共 50 条
  • [21] Induced pluripotent stem cells in the study of neurological diseases
    Saporta, Mario A.
    Grskovic, Marica
    Dimos, John T.
    STEM CELL RESEARCH & THERAPY, 2011, 2
  • [22] Induced Pluripotent Stem Cells to Model Blood Diseases
    Papapetrou, Eirini P.
    BLOOD, 2018, 132
  • [23] Application of Induced Pluripotent Stem Cells in Liver Diseases
    Yu, Yue
    Wang, Xuehao
    Nyberg, Scott L.
    CELL MEDICINE, 2014, 7 (01): : 1 - 13
  • [24] Induced pluripotent stem cells for modelling human diseases
    Unternaehrer, Juli J.
    Daley, George Q.
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2011, 366 (1575) : 2274 - 2285
  • [25] Induced Pluripotent Stem Cells as a Novel Tool in Psychiatric Research
    Kim, Sewoong
    Kim, Min-Kyoung
    Oh, Daeyoung
    Lee, Sang-Hyuk
    Kim, Borah
    PSYCHIATRY INVESTIGATION, 2016, 13 (01) : 8 - 17
  • [26] Modeling rare diseases with induced pluripotent stem cell technology
    Anderson, Ruthellen H.
    Francis, Kevin R.
    MOLECULAR AND CELLULAR PROBES, 2018, 40 : 52 - 59
  • [27] Human induced pluripotent stem cell for modeling cardiovascular diseases
    Liang, Ping
    Du, Jie
    REGENERATIVE MEDICINE RESEARCH, 2014, 2
  • [28] Primary immunodeficiency modeling with induced pluripotent stem cells
    Pessach, Itai M.
    Notarangelo, Luigi D.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 11 (06) : 505 - 511
  • [29] Human disease modeling with induced pluripotent stem cells
    Trounson, Alan
    Shepard, Kelly A.
    DeWitt, Natalie D.
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2012, 22 (05) : 509 - 516
  • [30] Modeling Keratoconus Using Induced Pluripotent Stem Cells
    Joseph, Roy
    Srivastava, Om P.
    Pfister, Roswell R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (08) : 3685 - 3697